{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:30:26Z","timestamp":1791559826286,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273096"],"award-info":[{"award-number":["82273096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030021"],"award-info":[{"award-number":["82030021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507500"],"award-info":[{"award-number":["2023YFC2507500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-024-01661-2","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T16:09:18Z","timestamp":1733414958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cell-permeated peptide P-T3H2 inhibits malignancy on hepatocellular carcinoma through stabilizing HNF4\u03b1 protein"],"prefix":"10.1007","volume":"15","author":[{"given":"Si-Han","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Chao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Yu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Fen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"1661_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1661_CR2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med"},{"key":"1661_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, et al. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42:180\u201397.","journal-title":"Cancer Cell"},{"key":"1661_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.tcb.2016.11.002","volume":"27","author":"PA Eyers","year":"2017","unstructured":"Eyers PA, Keeshan K, Kannan N. Tribbles in the 21st century: the evolving roles of tribbles pseudokinases in biology and disease. Trends Cell Biol. 2017;27:284\u201398.","journal-title":"Trends Cell Biol"},{"key":"1661_CR5","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1038\/ncomms8951","volume":"6","author":"F Hua","year":"2015","unstructured":"Hua F, Li K, Yu JJ, Lv XX, Yan J, Zhang XW, et al. TRB3 links insulin\/IGF to tumour promotion by interacting with p62 and impeding autophagic\/proteasomal degradations. Nat Commun. 2015;6:7951.","journal-title":"Nat Commun"},{"issue":"708\u2013721","key":"1661_CR6","volume":"156","author":"F Hua","year":"2019","unstructured":"Hua F, Shang S, Yang YW, Zhang HZ, Xu TL, Yu JJ, et al. TRIB3 interacts with beta-catenin and TCF4 to increase stem cell features of colorectal cancer stem cells and tumorigenesis. Gastroenterology. 2019;156(708\u2013721): e715.","journal-title":"Gastroenterology"},{"issue":"697\u2013710","key":"1661_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.04.006","volume":"31","author":"K Li","year":"2017","unstructured":"Li K, Wang F, Cao WB, Lv XX, Hua F, Cui B, et al. TRIB3 promotes APL progression through stabilization of the oncoprotein PML-RARalpha and inhibition of p53-mediated senescence. Cancer Cell. 2017;31(697\u2013710): e697.","journal-title":"Cancer Cell"},{"key":"1661_CR8","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.1123374","volume":"312","author":"L Qi","year":"2006","unstructured":"Qi L, Heredia JE, Altarejos JY, Screaton R, Goebel N, Niessen S, et al. TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science. 2006;312:1763\u20136.","journal-title":"Science"},{"key":"1661_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.05.009","volume":"382","author":"X Ren","year":"2019","unstructured":"Ren X, Chen N, Chen Y, Liu W, Hu Y. TRB3 stimulates SIRT1 degradation and induces insulin resistance by lipotoxicity via COP1. Exp Cell Res. 2019;382: 111428.","journal-title":"Exp Cell Res"},{"key":"1661_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/CBM-201577","volume":"29","author":"XJ Wang","year":"2020","unstructured":"Wang XJ, Li FF, Zhang YJ, Jiang M, Ren WH. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis. Cancer Biomark. 2020;29:307\u201315.","journal-title":"Cancer Biomark"},{"key":"1661_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1080\/15548627.2019.1635383","volume":"16","author":"XW Zhang","year":"2020","unstructured":"Zhang XW, Zhou JC, Peng D, Hua F, Li K, Yu JJ, et al. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation. Autophagy. 2020;16:782\u201396.","journal-title":"Autophagy"},{"issue":"5","key":"1661_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jhep.2023.12.029","volume":"80","author":"MC Xiao","year":"2024","unstructured":"Xiao MC, Jiang N, Chen LL, et al. TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4\u03b1 stability. J Hepatol. 2024;80(5):778\u201391.","journal-title":"J Hepatol"},{"key":"1661_CR13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1097\/CM9.0000000000002092","volume":"135","author":"X Pan","year":"2022","unstructured":"Pan X, Zhang Y. Hepatocyte nuclear factor 4alpha in the pathogenesis of non-alcoholic fatty liver disease. Chin Med J (Engl). 2022;135:1172\u201381.","journal-title":"Chin Med J (Engl)"},{"key":"1661_CR14","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1158\/0008-5472.CAN-10-0824","volume":"70","author":"BF Ning","year":"2010","unstructured":"Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, et al. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res. 2010;70:7640\u201351.","journal-title":"Cancer Res"},{"key":"1661_CR15","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2011.10.043","volume":"147","author":"M Hatziapostolou","year":"2011","unstructured":"Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, et al. An HNF4\u03b1 lpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell. 2011;147:1233\u201347.","journal-title":"Cell"},{"key":"1661_CR16","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/hep.27177","volume":"60","author":"BF Ning","year":"2014","unstructured":"Ning BF, Ding J, Liu J, Yin C, Xu WP, Cong WM, et al. Hepatocyte nuclear factor 4alpha-nuclear factor-kappaB feedback circuit modulates liver cancer progression. Hepatology. 2014;60:1607\u201319.","journal-title":"Hepatology"},{"key":"1661_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/gut.2008.174904","volume":"59","author":"HY Yue","year":"2010","unstructured":"Yue HY, Yin C, Hou JL, Zeng X, Chen YX, Zhong W, et al. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats. Gut. 2010;59:236\u201346.","journal-title":"Gut"},{"key":"1661_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev-pharmtox-011613-140028","volume":"54","author":"L Jin","year":"2014","unstructured":"Jin L, Wang W, Fang G. Targeting protein-protein interaction by small molecules. Annu Rev Pharmacol Toxicol. 2014;54:435\u201356.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1661_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd.2016.29","volume":"15","author":"DE Scott","year":"2016","unstructured":"Scott DE, Bayly AR, Abell C, Skidmore J. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Nat Rev Drug Discov. 2016;15:533\u201350.","journal-title":"Nat Rev Drug Discov"},{"key":"1661_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","volume":"18","author":"A Cuadrado","year":"2019","unstructured":"Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019;18:295\u2013317.","journal-title":"Nat Rev Drug Discov"},{"key":"1661_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.1092472","volume":"303","author":"LT Vassilev","year":"2004","unstructured":"Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004;303:844\u20138.","journal-title":"Science"},{"key":"1661_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468\u201372.","journal-title":"Science"},{"key":"1661_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/hep.22396","volume":"48","author":"SS Lee","year":"2008","unstructured":"Lee SS, Cha EY, Jung HJ, Shon JH, Kim EY, Yeo CW, Shin JG. Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity. Hepatology. 2008;48:635\u201345.","journal-title":"Hepatology"},{"key":"1661_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155909","volume":"155","author":"X Pan","year":"2024","unstructured":"Pan X, Hu S, Xu Y, Gopoju R, Zhu Y, Cassim Bawa FN, Wang H, Wang J, Batayneh Z, Clark A, Zeng Y, Lin L, Wang X, Yin L, Zhang Y. Kruppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4\u03b1 lpha-mediated metabolic pathways. Metabolism. 2024;155: 155909.","journal-title":"Metabolism"},{"key":"1661_CR25","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/hep.22510","volume":"48","author":"C Yin","year":"2008","unstructured":"Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology. 2008;48:1528\u201339.","journal-title":"Hepatology"},{"key":"1661_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/mc.22294","volume":"55","author":"HS Yao","year":"2016","unstructured":"Yao HS, Wang J, Zhang XP, Wang LZ, Wang Y, Li XX, Jin KZ, Hu ZQ, Wang WJ. Hepatocyte nuclear factor 4alpha suppresses the aggravation of colon carcinoma. Mol Carcinog. 2016;55:458\u201372.","journal-title":"Mol Carcinog"},{"key":"1661_CR27","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/hep.31604","volume":"73","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhu Y, Hu S, Xu Y, Stroup D, Pan X, Bawa FC, Chen S, Gopoju R, Yin L, Zhang Y. Hepatocyte nuclear factor 4alpha prevents the steatosis-to-NASH progression by regulating p53 and bile acid signaling (in mice). Hepatology. 2021;73:2251\u201365.","journal-title":"Hepatology"},{"key":"1661_CR28","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/hep.29661","volume":"67","author":"Y Liang","year":"2018","unstructured":"Liang Y, Feng Y, Zong M, Wei XF, Lee J, Feng Y, et al. beta-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic beta-catenin and MET. Hepatology. 2018;67:1807\u201322.","journal-title":"Hepatology"},{"key":"1661_CR29","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/hep.28601","volume":"64","author":"J Tao","year":"2016","unstructured":"Tao J, Xu E, Zhao Y, Singh S, Li X, Couchy G, et al. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant beta-catenin. Hepatology. 2016;64:1587\u2013605.","journal-title":"Hepatology"},{"key":"1661_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrc3690","volume":"14","author":"TL Nero","year":"2014","unstructured":"Nero TL, Morton CJ, Holien JK, Wielens J, Parker MW. Oncogenic protein interfaces: small molecules, big challenges. Nat Rev Cancer. 2014;14:248\u201362.","journal-title":"Nat Rev Cancer"},{"key":"1661_CR31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tips.2021.11.008","volume":"43","author":"M Buyanova","year":"2022","unstructured":"Buyanova M, Pei D. Targeting intracellular protein-protein interactions with macrocyclic peptides. Trends Pharmacol Sci. 2022;43:234\u201348.","journal-title":"Trends Pharmacol Sci"},{"issue":"1009\u20131021","key":"1661_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.03.021","volume":"35","author":"L Gu","year":"2023","unstructured":"Gu L, Zhu Y, Watari K, Lee M, Liu J, Perez S, et al. Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness. Cell Metab. 2023;35(1009\u20131021): e1009.","journal-title":"Cell Metab"},{"key":"1661_CR33","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s43018-023-00626-8","volume":"4","author":"W Dong","year":"2023","unstructured":"Dong W, Fekete A, Chen X, Liu H, Beilhartz GL, Chen X, et al. A designer peptide against the EAG2-Kvbeta2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma. Nat Cancer. 2023;4:1418\u201336.","journal-title":"Nat Cancer"},{"issue":"4","key":"1661_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2021.140604","volume":"1869","author":"GC Kim","year":"2021","unstructured":"Kim GC, Cheon DH, Lee Y. Challenge to overcome current limitations of cell-penetrating peptides. Biochim Biophys Acta Proteins Proteom. 2021;1869(4): 140604.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"issue":"10","key":"1661_CR35","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/psc.2672","volume":"20","author":"S Reissmann","year":"2014","unstructured":"Reissmann S. Cell penetration: scope and limitations by the application of cell-penetrating peptides. J Pept Sci. 2014;20(10):760\u201384.","journal-title":"J Pept Sci"},{"key":"1661_CR36","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.3748\/wjg.v25.i30.4074","volume":"25","author":"MM Yeh","year":"2019","unstructured":"Yeh MM, Bosch DE, Daoud SS. Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases. World J Gastroenterol. 2019;25:4074\u201391.","journal-title":"World J Gastroenterol"},{"key":"1661_CR37","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/hep.32326","volume":"76","author":"S Gunewardena","year":"2022","unstructured":"Gunewardena S, Huck I, Walesky C, Robarts D, Weinman S, Apte U. Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans. Hepatology. 2022;76:372\u201386.","journal-title":"Hepatology"},{"issue":"6","key":"1661_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00428-014-1574-x","volume":"464","author":"RS van der Post","year":"2014","unstructured":"van der Post RS, Bult P, Vogelaar IP, Ligtenberg MJ, Hoogerbrugge N, van Krieken JH. HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma. Virchows Arch. 2014;464(6):673\u20139.","journal-title":"Virchows Arch"},{"key":"1661_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12935-019-0767-4","volume":"19","author":"Q Sun","year":"2019","unstructured":"Sun Q, Xu W, Ji S, et al. Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma. Cancer Cell Int. 2019;19:49.","journal-title":"Cancer Cell Int"},{"key":"1661_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/1751-2980.12122","volume":"15","author":"WP Xu","year":"2014","unstructured":"Xu WP, Zhang X, Xie WF. Differentiation therapy for solid tumors. J Dig Dis. 2014;15:159\u201365.","journal-title":"J Dig Dis"},{"key":"1661_CR41","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1080\/10408398.2018.1509201","volume":"59","author":"X Ni","year":"2019","unstructured":"Ni X, Hu G, Cai X. The success and the challenge of all-trans retinoic acid in the treatment of cancer. Crit Rev Food Sci Nutr. 2019;59:S71\u201380.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1661_CR42","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/hep.24647","volume":"54","author":"X Zeng","year":"2011","unstructured":"Zeng X, Lin Y, Yin C, Zhang X, Ning BF, Zhang Q, et al. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology. 2011;54:2036\u201347.","journal-title":"Hepatology"},{"key":"1661_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41422-018-0111-x","volume":"29","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, He Z, Cai Y, Zhang C, Fu G, Li H, et al. Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors. Cell Res. 2019;29:124\u201335.","journal-title":"Cell Res"},{"key":"1661_CR44","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","volume":"20","author":"E Kon","year":"2023","unstructured":"Kon E, Ad-El N, Hazan-Halevy I, Stotsky-Oterin L, Peer D. Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects. Nat Rev Clin Oncol. 2023;20:739\u201354.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01661-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T17:05:31Z","timestamp":1733418331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01661-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01661-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients whose specimens were utilized in this study have signed the informed consent form granting permission for the use of their specimens in scientific research. All methods were performed in accordance with the guiding principles of the Medical Research Ethics Committee of Naval Medical University. All animal experiments in this study were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Medical Research Ethics Committee of Naval Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"752"}}